Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \0 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \A \l \i \m \e \r \a \space \S \c \i \e \n \c \e \s \, \ \a \space \b \i \o \p \h \a \r \m \a \c \e \u \t \i \c \a \l \space \c \o \m \p \a \n \y \space \t \h \a \t \space \s \p \e \c \i \a \l \i \z \e \s \space \i \n \space \t \h \e \space \r \e \s \e \a \r \c \h \, \space \d \e \v \e \l \o \p \m \e \n \t \space \a \n \d \space \c \o \m \m \e \r \c \i \a \l \i \z \a \t \i \o \n \space \o \f \space \p \r \e \s \c \r \i \p \t \i \o \n \space \o \p \h \t \h \a \l \m \i \c \space \p \h \a \r \m \a \c \e \u \t \i \c \a \l \s \, \space \t \o \d \a \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\3 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \P \a \t \i \e \n \t \s \space \a \n \d \space \d \o \c \t \o \r \s \space \i \n \space \S \c \o \t \l \a \n \d \space \a \r \e \space \t \o \space \h \a \v \e \space \a \space \g \r \e \a \t \e \r \space \s \a \y \space \o \v \e \r \space \w \h \i \c \h \space \d \r \u \g \s \space \f \o \r \space \r \a \r \e \space \c \o \n \d \i \t \i \o \n \s " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \S \e \p \t \e \m \b \e \r \space \2 \0 \1 \3 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \7 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \ \T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \S \e \n \i \o \r \space \d \o \c \t \o \r \s \space \i \n \v \o \l \v \e \d \space \i \n \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \c \a \n \c \e \r \space \p \a \t \i \e \n \t \s \space \h \a \v \e \space \s \a \i \d \space \m \a \n \y \space \o \f \space \t \h \e \m \space \a \r \e \space \n \o \t \space \g \e \t \t \i \n \g " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
In October 2013, the Scottish Government published its response to the Health and Sport Committee inquiry into access to new medicines. This recommended ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\6 \space \M \a \y \space \2 \0 \1 \4 \space \- \ " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \3 \space \M \a \r \c \h \ \2 \0 \1 \4 \space \- \ \T \h \e \space \S \M \C \space \a \d \v \i \c \e \space \f \o \r \space \M \a \r \c \h \space \2 \0 \1 \4 \space \h \a \s \space \b \e \e \n \space \e \n \t \e \r \e \d \space \i \n \t \o \space \M \A \E \S \T \r \O \space \S \c \o \t \l \a \n \d \. " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content (" ...")]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Drug manufacturers have been accused of demanding too much money for life-extending medication after a second cutting-edge breast cancer treatment within ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The Scottish Medicines Consortium (SMC) has today published advice accepting four new medicines for use in NHS Scotland. ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Everolimus (Afinitor) is not recommended for use within NHS Scotland for the treatment of hormone receptor-positive, human epidermal growth factor type
...
Read more →
Posted by Michael Wonder on 05 Aug 2015
From today patients in Scotland with chronic lymphocytic leukaemia (CLL) have gained ‘routine’ access to a new treatment option after ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\2 \6 \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \4 \space \- \ \A \n \space \o \v \e \r \h \a \u \l \space \i \n \space \t \h \e \space \w \a \y \space \l \i \f \e \s \a \v \i \n \g \space \d \r \u \g \s \space \a \r \e \space \a \p \p \r \o \v \e \d \space \f \o \r \space \u \s \e \space \i \n \space \S \c \o \t \l \a \n \d \space \c \o \u \l \d \space \l \e \a \v \e \space \a \space \Â \£ \5 \0 " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Below a list of forthcoming submissions that have recently been added to the SMC's programme. Information in relation to the drug ...
Read more →